Photo: Cheng Xin/Getty Images 6 minute read Click to share on Facebook (Opens in new window/tab) Click to share on X (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab) The US Department of the Treasury’s proposed biotechnology restrictions would generally leave standalone drug licenses outside the US outbound investment regime.
David Plotinsky
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with David
Contact David, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack